[HTML][HTML] Targeting bacterial central metabolism for drug development
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
[PDF][PDF] Targeting Bacterial Central Metabolism for Drug Development
P Murima, JD McKinney, K Pethe - Chemistry & Biology, 2014 - academia.edu
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
[HTML][HTML] Targeting Bacterial Central Metabolism for Drug Development
P Murima, JD McKinney, K Pethe - Chemistry & Biology, 2014 - Elsevier
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
Targeting Bacterial Central Metabolism for Drug Development
P Murima, JD McKinney, K Pethe - Chemistry & Biology, 2014 - infona.pl
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
Targeting bacterial central metabolism for drug development.
P Murima, JD McKinney, K Pethe - Chemistry & biology, 2014 - sonar.ch
English Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of
cellular processes, namely DNA replication, protein synthesis, and cell wall biosynthesis …
cellular processes, namely DNA replication, protein synthesis, and cell wall biosynthesis …
Targeting bacterial central metabolism for drug development.
P Murima, JD McKinney, K Pethe - Chemistry & Biology, 2014 - europepmc.org
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
[PDF][PDF] Targeting Bacterial Central Metabolism for Drug Development
P Murima, JD McKinney, K Pethe - Chemistry & Biology, 2014 - core.ac.uk
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
Targeting bacterial central metabolism for drug development
P Murima, JD McKinney, K Pethe - Chemistry & biology, 2014 - pubmed.ncbi.nlm.nih.gov
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
Targeting Bacterial Central Metabolism for Drug Development
P Murima, JD Mckinney, K Pethe - Chemistry & Biology, 2014 - infoscience.epfl.ch
Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …
processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the …